Clinical trials
Phase 3 Head and Neck Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Boehringer Ingelheim | 2 |
| Sun Yat-sen University | 2 |
| Adlai Nortye Biopharma Co., Ltd. | 1 |
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Fudan University | 1 |
| Guangzhou Double Bioproducts Co., Ltd | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 21 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Nasopharyngeal Carcinoma | 2 |
| Nasopharyngeal Diseases | 2 |
| Nasopharyngeal Neoplasms | 2 |
| Hypopharyngeal Neoplasms | 1 |
| Laryngeal Diseases | 1 |
| Laryngeal Neoplasms | 1 |
| Neoplasms | 1 |
| Oropharyngeal Neoplasms | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.